— Know what they know.
Not Investment Advice

002252.SZ

Shanghai RAAS Blood Products Co., Ltd.
1W: -5.3% 1M: -6.4% 3M: -15.2% YTD: -7.6% 1Y: -14.8% 3Y: +3.9% 5Y: -26.7%
¥5.83 ($0.84)
-0.03 (-0.51%)
 
SHZ · Healthcare · Biotechnology · ¥38.9B
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap¥38.9B ($5.6B)
52W Range5.83-7.3
Volume18,307,226
Avg Volume33,253,540
Beta0.42
Dividend¥0.05
Analyst Ratings
No analyst coverage
Company Info
CEOJun Xu
Employees3,350
SectorHealthcare
IndustryBiotechnology
IPO Date2008-06-12
No. 2009, Wangyuan Road
Shanghai 201401
CN
86 21 2213 0888
About Shanghai RAAS Blood Products Co., Ltd.

Shanghai RAAS Blood Products Co., Ltd. engages in the manufacture and sale of blood products in China. It offers human albumin, human intravenous immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, human fibrinogen, human thrombin and human fibrin sealant, human immunoglobulin, hepatitis B immunoglobulin, tetanus immunoglobulin, and rabies immunoglobulin products. It also provides testing services for blood products, vaccines, diagnostic reagents, and testing equipment. The company also exports its products to Southeast Asia and Latin America. Shanghai RAAS Blood Products Co., Ltd. was founded in 1988 and is based in Shanghai, China.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms